← Return to Breast cancer patient also with osteoporosis: AI, Prolia and Reclast
DiscussionBreast cancer patient also with osteoporosis: AI, Prolia and Reclast
Breast Cancer | Last Active: Apr 8 9:33am | Replies (23)Comment receiving replies
Replies to "@gently I worry that the effects of sclerostin suppression are not adequately studied. Most studies are..."
At least the restricted plasma level of the bone-derived protein, SOST, is correlated with reduced brain Aβ load in a cognitively unimpaired older adults. https://www.ncbi.nlm.nih.gov/pmc/issues/427415/
My concern is cardiac valves.
I think the reluctance to prescribe is entirely the evidence from rats predisposed to cancer. The registery that allowed the elimination of the black box would have to have been skewed, who would prescribe and who would take the risk. Mostly white women of our age. But no mechanism of action has been proposed.
The internet is rife with the now retracted warnings. I wish at least the universities would delete the disproven information from their sites.
I spoke with an endocrinologist last week who was not aware of the change for Forteo and skeptical of its existence.
I would so love to hear your dreams.